Sergio Matarraz

Standardization of flow cytometry in myelodysplastic syndromes: a report from an international consortium and the European LeukemiaNet Working Group

Theresia M. Westers, Robin Ireland, Wolfgang Kern et al. · Leukemia · 2012 · 243 citations · Full text

Hematological Malignancy, Flow Cytometry, Myelodysplastic Syndromes +12

Revisiting guidelines for integration of flow cytometry results in the WHO classification of myelodysplastic syndromes—proposal from the International/European LeukemiaNet Working Group for Flow Cytometry in MDS

Anna Porwit, Arjan A. van de Loosdrecht, Peter Bettelheim et al. · Leukemia · 2014 · 145 citations

Hematological Malignancy, Flow Cytometry, Medicine +10

The immunophenotype of different immature, myeloid and B-cell lineage-committed CD34+ hematopoietic cells allows discrimination between normal/reactive and myelodysplastic syndrome precursors

Sergio Matarraz, Antonio López, S Bárrena et al. · Leukemia · 2008 · 122 citations

Hematological Malignancy, Different Immature, Immunology +8

Bone marrow cells from myelodysplastic syndromes show altered immunophenotypic profiles that may contribute to the diagnosis and prognostic stratification of the disease: A pilot study on a series of 56 patients

Sergio Matarraz, Antonio López, Susana Bárrena et al. · Cytometry Part B Clinical Cytometry · 2010 · 99 citations · Full text

Immunophenotypic analysis of erythroid dysplasia in myelodysplastic syndromes. A report from the IMDSFlow working group

Theresia M. Westers, Eline M.P. Cremers, Uta Oelschlaegel et al. · Haematologica · 2016 · 96 citations · Full text